Director, Early Value Lead - Oncology
Boehringer Ingelheim
- Ridgefield, CT
- Permanent
- Full-time
- Develops indication specific US Early Value Strategies for assigned therapeutic areas containing early pricing, market access, optimized launch sequencing and payor value proposition strategy and including payer insights with IRA considerations to optimize likelihood of success for assets and indications in the U.S. Market.
- Revises and updates strategy throughout the clinical development program as guided by the market access excellence framework.
- Leads pricing strategy efforts for BIPI, in coordination with Corporate Market Access colleagues, including testing of eTPPs, understanding volume and access trade-offs and inclusion of receptivity and expectations among stakeholders to engage in innovative contracting strategies to inform forecasting assumptions.
- Co-creates global deliverables such as Asset Narrative, Asset Evidence Plan, eTPPs, IAPs, and execution of local strategic and operational outputs such as Early Indication Assessments, Asset Maximization workstreams, Channel Mix Assessment, Competitive Landscape, Patient Journey, Flow of the Dollar. etc. across major clinical development milestones for each asset and indication.
- Collaborates with eAT Evidence and Team Lead as well as knowledge network including marketing, policy, HEOR, regulatory, finance, GTN, forecasting and corporate colleagues to capture relevant payor insights, identify data gaps, and through close alignment with evidence lead and HEOR, ensures evidence generation and pricing is aligned to a compelling value proposition.
- Leads early efforts to proactively identify innovative and customer-focused contracting strategies that will maximize access and net sales. This includes interacting with payor customers to understand their perception of the product value and working with Value Leads, Contracting and HEOR colleagues to define options for traditional and/or outcomes-based agreements.
- Bachelor's degree required. Master's degree (e.g., MBA, MSc) preferred.
- Ten (10) years of relevant experience in the pharmaceutical industry with a minimum of five (5) years' experience in Managed Markets/Market Access role.
- Minimum of three (3) years project or people leadership experience.
- Must have in-depth knowledge of US pricing, reimbursement systems and channels as well as strong clinical, health economic and scientific knowledge.
- Deep understanding of U.S. payer needs.
- Ability to lead and influence without authority across cross-functional teams.
- Demonstrated ability to create and drive strategy.
- Demonstrated ability in teamwork and collaboration.
- Demonstrated project management skills.
- Demonstrated communication and leadership skills.
- Demonstrated ability to manage budget and resources.
- Demonstrated ability to achieve results in a highly matrixed organization.
- History of successful performance.
- Ability to travel (may include overnight travel).
- Must be legally authorized to work in the United States without restriction.
- Must be willing to take a drug test and post-offer physical (if required).
- Must be 18 years of age or older.